These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 32193733

  • 1. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Skrabal D, Tykalova T, Klempir J, Ruzicka E, Rusz J.
    J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S, Shukla G, Goyal V, Singh S, Aggarwal V, Gureshkumar, Behari M.
    Neurol India; 2008 Jun; 56(2):122-6. PubMed ID: 18688134
    [Abstract] [Full Text] [Related]

  • 4. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Tykalova T, Rusz J, Klempir J, Cmejla R, Ruzicka E.
    Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ, Siuda J.
    Neurol Neurochir Pol; 2024 Feb; 58(2):193-202. PubMed ID: 38148738
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Parkinsonism-associated speech disorders].
    Skripkina NA, Arefyeva AP.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020 Dec; 120(10. Vyp. 2):61-66. PubMed ID: 33205932
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M, Petrović I, Ječmenica-Lukić M, Radovanović S, Dragašević-Mišković N, Belić M, Miler-Jerković V, Popović MB, Kostić VS.
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Posturographic abnormalities in ambulatory atypical parkinsonian disorders: Differentiating characteristics.
    Panyakaew P, Anan C, Bhidayasiri R.
    Parkinsonism Relat Disord; 2019 Sep; 66():94-99. PubMed ID: 31337595
    [Abstract] [Full Text] [Related]

  • 20. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.